Leptin Transport Across the Blood-Brain Barrier: Implications for the Cause and Treatment of Obesity
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
125-133
Author(s):
William A. Banks
Involvement of Tachykinins in Intestinal Inflammation
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
19-30
Author(s):
S. Evangelista
The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Journal:
Current Drug Targets
Volume:
1
Page:
327-364
Author(s):
M. Gardnerova, R. Blanque and C. R. Gardner
A Survey of Calpain Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1171-1188
Author(s):
I. O. Donkor
Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Journal:
Current Drug Targets
Volume:
1
Page:
247-260
Author(s):
M. A. Khan, R. C. Calvert, M. E. Sullivan, C. S. Thomson, F. H. Mumtaz, R. J. Morgan and D. P. Mikhailidis
Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1101-1112
Author(s):
G. Dannhardt and S. Laufer
COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1113-1120
Author(s):
C. Hoffmann
COX-2 Selectivity and Inflammatory Processes
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1145-1161
Author(s):
Joanne van Ryn, Gnnter Trummlitz and Michel Pairet
Clinical Experience with Specific COX-2 Inhibitors in Arthritis
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1725-1736
Author(s):
Leslie J. Crofford
Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1755-1776
Author(s):
A. Yermakova and M. K. O'Banion